Stock KBLM 180 LIFE SCIENCES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News 180 Life Sciences Corp.

Equities

KBLM

US68236V3024

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
2.13 USD -7.79% Intraday chart for 180 Life Sciences Corp. +36.54% -47.49%
May. 15 180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 09 180 Life Sciences Corp. Announces Management Changes CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
AQ
180 Life Sciences : Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements Form 8 K
PU
180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
180 Life Sciences Corp. Announces Management Changes
CI
180 Life Sciences Corp. Announces Chief Executive Officer Changes
CI
180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
180 Life Sciences : Corporate Presentation
PU
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
AQ
180 Life Sciences Corp. Announces Board Changes
CI
180 Life Sciences Corp. Appoints Blair Jordan as A Member of the Board of Directors
CI
180 Life Sciences to Conduct 1-For-19 Reverse Stock Split
MT
180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
AQ
180 Life Sciences Corp. announced a financing transaction
CI
180 Life Sciences Corp. Announces Board Resignations
CI
180 Life Sciences Corp. Announces Resignation of Donald A. Mcgovern, as Member of the Board of Directors
CI
180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternatives
CI
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
AQ
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
CI
180 Life Sciences : Material Agreement - Form 8-K
PU
180 Life Sciences Announces Review of Strategic Alternatives
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KBLM Stock
  4. News 180 Life Sciences Corp.